New Two-Pronged attack on obesity and insulin resistance
NCT ID NCT05713799
Summary
This study is testing whether combining a dietary supplement (alpha-lipoic acid) with an existing medication (mirabegron) can help the body process sugar and burn fat more effectively in people with obesity. Researchers will enroll 60 adults with obesity to take the combination for four weeks and measure changes in insulin sensitivity and fat breakdown. The goal is to see if this combination offers a better approach to managing obesity-related metabolic issues than the drug alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.